Tesamorelin 5mg is a synthetic growth hormone-releasing hormone (GHRH) analogue designed for research purposes. This peptide stimulates the pituitary gland to release endogenous growth hormone, which subsequently increases levels of insulin-like growth factor 1 (IGF-1). Elevated IGF-1 levels have been associated with various metabolic benefits, including the reduction of visceral adipose tissue (VAT), enhancement of lean muscle mass, and improvement in lipid profiles. In clinical studies, Tesamorelin has demonstrated a significant decrease in VAT, with participants experiencing an average reduction of 15.2% over 26 weeks . Additionally, Tesamorelin has been shown to improve cholesterol ratios and lower triglyceride levels. It is important to note that Tesamorelin is not intended for weight loss management but rather for the reduction of excess abdominal fat in specific populations, such as HIV-infected adults with lipodystrophy .
Important Note: Tesamorelin is intended solely for research purposes and should be used under the supervision of qualified professionals. It is not approved for human or veterinary use outside of specific clinical indications. Always consult with a healthcare provider before considering any peptide therapy.






Reviews
There are no reviews yet.